Literature DB >> 19199931

Anti-inflammatory effects of fibrates: an overview.

Konstantinos Tziomalos1, Vasilios G Athyros, Asterios Karagiannis, Dimitri P Mikhailidis.   

Abstract

Inflammation plays an important role in the pathogenesis of atherosclerosis. Several cardiovascular drugs exert anti-inflammatory effects and accumulating data suggest that fibrates also share this property. This review summarizes the mechanisms implicated in the anti-inflammatory actions of fibrates. We also provide an overview of the existing clinical studies addressing the effects of fibrates on markers of inflammation. Several, but not all, studies reported that fibrates exert anti-inflammatory actions. The small number of patients included in some studies, as well as differences in diagnoses and duration of follow up might partly explain this discrepancy. It is also possible that fibrates differ substantially in terms of anti-inflammatory effects. It is not clear whether an anti-inflammatory action of fibrates is clinically relevant. Future studies should assess whether the anti-inflammatory actions of fibrates (or for that matter, other drugs) will translate into a reduced risk of vascular disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199931     DOI: 10.2174/092986709787458416

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  8 in total

1.  Dehydroepiandrosterone replacement therapy in older adults improves indices of arterial stiffness.

Authors:  Edward P Weiss; Dennis T Villareal; Ali A Ehsani; Luigi Fontana; John O Holloszy
Journal:  Aging Cell       Date:  2012-08-01       Impact factor: 9.304

2.  Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study.

Authors:  Annick Alpérovitch; Tobias Kurth; Marion Bertrand; Marie-Laure Ancelin; Catherine Helmer; Stéphanie Debette; Christophe Tzourio
Journal:  BMJ       Date:  2015-05-19

3.  Synthesis of a Novel Siliconized Analog of Clofibrate (Silafibrate) and Comparison of their Anti-inflammatory Activities.

Authors:  Mojtaba Ziaee; Morteza Samini; Mohammad Bolourtchian; Mohammad Ghaffarzadeh; Maryam Ahmadi; Mohammad Ali Egbal; Arash Khorrami; Sina Andalib; Nasrin Maleki-Dizaji; Alireza Garjani
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

4.  Role of lipid-lowering agents in the management of diabetic retinopathy.

Authors:  Estelle Ioannidou; Vasilis-Spyridon Tseriotis; Konstantinos Tziomalos
Journal:  World J Diabetes       Date:  2017-01-15

5.  Current evidence on the role of lipid lowering drugs in the treatment of psoriasis.

Authors:  Jiao Wang; Shuo Zhang; Meng Xing; Seokgyeong Hong; Liu Liu; Xiao-Jie Ding; Xiao-Ying Sun; Ying Luo; Chun-Xiao Wang; Miao Zhang; Bin Li; Xin Li
Journal:  Front Med (Lausanne)       Date:  2022-08-11

6.  Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers.

Authors:  Laura J Cobb; Changhan Lee; Jialin Xiao; Kelvin Yen; Richard G Wong; Hiromi K Nakamura; Hemal H Mehta; Qinglei Gao; Carmel Ashur; Derek M Huffman; Junxiang Wan; Radhika Muzumdar; Nir Barzilai; Pinchas Cohen
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

Review 7.  Lipid-based gene delivery to macrophage mitochondria for atherosclerosis therapy.

Authors:  Felix H Zakirov; Dongwei Zhang; Andrey V Grechko; Wei-Kai Wu; Anastasia V Poznyak; Alexander N Orekhov
Journal:  Pharmacol Res Perspect       Date:  2020-04

8.  Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-α/γ) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.

Authors:  Haifa M AlNafea; Aida A Korish
Journal:  PPAR Res       Date:  2021-07-09       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.